Date published: 2025-10-19

1-800-457-3801

SCBT Portrait Logo
Seach Input

1,2-Distearoyl-sn-glycero-3-phospho-rac-glycerol sodium salt (CAS 200880-42-8)

0.0(0)
Write a reviewAsk a question

Alternate Names:
1,2-Dioctadecanoyl-sn-glycero-3-phospho-(1′-rac-glycerol) sodium salt; 1,2-Distearoyl-sn-glycero-3-phosphoglycerol; L-α-Phosphatidyl-DL-glycerol, distearoyl; DSPG-Na
CAS Number:
200880-42-8
Molecular Weight:
801.1
Molecular Formula:
C42H82O10P•Na
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

1,2-Distearoyl-sn-glycero-3-phospho-rac-glycerol sodium salt, commonly referred to as DSPG-Na, is a synthetic phospholipid that is integral to studies involving the structure and function of lipid bilayers. Composed of a glycerol backbone with two stearic acid chains esterified at the sn-1 and sn-2 positions, DSPG-Na forms highly rigid and less fluid lipid bilayers, mimicking the saturated lipid environment found in some biological membranes. The phospho-glycerol headgroup at the sn-3 position, negatively charged and counterbalanced by sodium, enables DSPG-Na to simulate the anionic properties of cell membranes, particularly useful in research focused on membrane dynamics and interactions. This compound is extensively used in biophysical experiments to explore how the presence of negatively charged lipids affects the behavior of proteins and other biomolecules within membranes, contributing significantly to our understanding of processes like vesicle formation, membrane fusion, and the structural roles of specific lipid compositions. DSPG-Na′s utility in these non-clinical applications provides essential insights into fundamental cellular mechanisms, helping to expand our knowledge of membrane biology without any direct therapeutic or pharmaceutical implications.


1,2-Distearoyl-sn-glycero-3-phospho-rac-glycerol sodium salt (CAS 200880-42-8) References

  1. Anti-αvβ3 antibody guided three-step pretargeting approach using magnetoliposomes for molecular magnetic resonance imaging of breast cancer angiogenesis.  |  Yan, C., et al. 2013. Int J Nanomedicine. 8: 245-55. PMID: 23345972
  2. Recent development of biotin conjugation in biological imaging, sensing, and target delivery.  |  Ren, WX., et al. 2015. Chem Commun (Camb). 51: 10403-18. PMID: 26021457
  3. Characterization of Lipid-Based Hexosomes as Versatile Vaccine Carriers.  |  Rodrigues, L., et al. 2016. Mol Pharm. 13: 3945-3954. PMID: 27607892
  4. Design of ultra-swollen lipidic mesophases for the crystallization of membrane proteins with large extracellular domains.  |  Zabara, A., et al. 2018. Nat Commun. 9: 544. PMID: 29416037
  5. Rheology of Ultraswollen Bicontinuous Lipidic Cubic Phases.  |  Speziale, C., et al. 2018. Langmuir. 34: 5052-5059. PMID: 29648837
  6. The interplay of channel geometry and molecular features determines diffusion in lipidic cubic phases.  |  Ghanbari, R., et al. 2019. J Chem Phys. 150: 094901. PMID: 30849886
  7. The Impact of Surface Drug Distribution on the Acoustic Behavior of DOX-Loaded Microbubbles.  |  Lin, CW., et al. 2021. Pharmaceutics. 13: PMID: 34959362
  8. Enhancing Doxorubicin Delivery in Solid Tumor by Superhydrophobic Amorphous Calcium Carbonate-Doxorubicin Silica Nanoparticles with Focused Ultrasound.  |  Chiang, PH., et al. 2022. Mol Pharm. 19: 3894-3905. PMID: 36018041
  9. The relationship between surface drug distribution of Dox-loaded microbubbles and drug release/cavitation behaviors with ultrasound.  |  Lin, CW., et al. 2024. Ultrason Sonochem. 102: 106728. PMID: 38103369
  10. Dynamic intervention to enhance the stability of PEGylated Ibrutinib loaded lipidic nano-vesicular systems: transitioning from colloidal dispersion to lyophilized product.  |  Panchal, K., et al. 2024. Drug Deliv Transl Res.. PMID: 38457026

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

1,2-Distearoyl-sn-glycero-3-phospho-rac-glycerol sodium salt, 50 mg

sc-220520
50 mg
$300.00